Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them

The present invention relates to compounds of the formulae I and Iain which X, Y, W, W, G and G have the meanings given in the patent claims, and their physiologically tolerable salts and their prodrugs, their preparation, their use, in particular as pharmaceutical active compounds, and pharmaceutic...

Full description

Saved in:
Bibliographic Details
Main Authors KNOLLE JOCHEN, PEYMAN ANUSCHIRWAN, GOURVEST JEAN-FRANCOIS, GADEK THOMAS RICHARD, BREIPOHL GERHARD, CARNIATO DENIS, WEHNER VOLKMAR
Format Patent
LanguageEnglish
Published 20.04.2004
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of the formulae I and Iain which X, Y, W, W, G and G have the meanings given in the patent claims, and their physiologically tolerable salts and their prodrugs, their preparation, their use, in particular as pharmaceutical active compounds, and pharmaceutical preparations comprising them. The compounds of the formula I are vitronectin receptor antagonists and can be employed, for example, as inhibitors of bone resorption and for the treatment of osteoporosis.
Bibliography:Application Number: US20000594033